Early change in faecal calprotectin during anti-TNFα initiation is strongly predictive of outcome in Crohn's disease

被引：0
|
作者：
Pavlidis, P. [1 ]
Chung-Faye, G. [1 ]
Dubois, P. [1 ]
Bjarnason, I. [1 ]
Hayee, B. H. [1 ]
机构：
[1] Kings Coll Hosp London, Dept Gastroenterol, London, England
来源：
JOURNAL OF CROHNS & COLITIS | 2016年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P470
引用
收藏
页码：S338 / S338
页数：1
相关论文
共 50 条
  • [41] Faecal calprotectin and plasma cytokines in the prediction of early postoperative Crohn's disease recurrence
    Cerrillo, E.
    Moret, I.
    Iborra, M.
    Hervas, D.
    Tortosa, L.
    Saez-Gonzalez, E.
    Nos, P.
    Beltran, B.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S257 - S257
  • [42] The changes in the faecal microbiome and metabolome in Crohn's disease after treatment with anti-TNF(sic) antibodies are of secondary origin
    Hurych, J.
    Bergo, A. Mascellani
    Lerchova, T.
    Ilinakova, L.
    Kubat, M.
    Malcova, H.
    Cebecauerova, D.
    Schwarz, J.
    Karaskova, E.
    Hecht, T.
    Vyhnanek, R.
    Toukalkova, L.
    Dotlacil, V.
    Kobrova, K.
    Cizkova, A.
    Horvath, R.
    Bronsky, J.
    Havlik, J.
    Hradsky, O.
    Cinek, O.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 1023 - 1024
  • [43] Soluble TNF serum levels during the induction phase in Crohn's Disease patients with anti-TNF treatment
    Chaparro, M.
    Guerra, I.
    Iborra, M.
    Cabriada, J. L.
    Bujanda, L.
    Taxonera, C.
    Garcia-Sanchez, V.
    Marin-Jimenez, I.
    Barreiro de-Acosta, M.
    Vera, I.
    Martin-Arranz, M. D.
    Hernandez-Breijo, B.
    Mesonero, F.
    Sempere, L.
    Arroyo, M. T.
    Hinojosa, M. D.
    Ramas, M.
    Algaba, A.
    Beltran, B.
    Rodriguez Pescador, A.
    Perugorria, M. J.
    Mendoza, J. L.
    Benitez-Cantero, J. M.
    Tardio, L.
    Ferreiro, R.
    Matallana Royo, V.
    Gomez Senent, S.
    Guijarro, L.
    Linares, P. M.
    Gisbert, J. P.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S302 - S302
  • [44] Anti-TNF Alpha Therapy and Orofacial Crohn's Disease in Pediatrics
    Chapuy, Laurence
    Deslandres, Colette
    INFLAMMATORY BOWEL DISEASES, 2012, 18 : S71 - S71
  • [45] Concomitant Use of Immunomodulators with Anti-TNF in Crohn's Disease: Yes or No?
    Meier, Johannes
    Sturm, Andreas
    CURRENT DRUG TARGETS, 2010, 11 (02) : 176 - 178
  • [46] Anti-TNF induction and maintenance therapy for refractory Crohn's disease
    Hartnell, F. L.
    Radford-Smith, G.
    Jones, L.
    Sewell, K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 62 - 62
  • [47] Local injection of anti-TNF for perianal fistulising Crohn's disease
    Ommer, A.
    COLOPROCTOLOGY, 2018, 40 (01) : 51 - 52
  • [48] Impact analysis of expanding anti-TNF therapy for Crohn's disease
    Honeycutt, Amanda
    Breck, Andrew
    Bass, Sarah
    Esposito, Dominick
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 11 (02) : 79 - 88
  • [49] Cryptosporidiosis in a patient with Crohn's disease under anti-TNF treatment
    Miranda, A.
    De Musis, C.
    Sgambato, D.
    De Mauro, D.
    Picascia, D.
    Avallone, L.
    Romano, L.
    Francesco, P.
    D'Armiento
    Romano, M.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2019, 82 (03) : 447 - 448
  • [50] SEVERE CARDIOMYOPATHY SECONDARY TO ANTI-TNF THERAPY FOR CROHN'S DISEASE
    Rezik, Mohamed
    Mattina, Deirdre
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 1042 - 1042
12345